0.00Open0.60Pre Close0 Volume4 Open Interest10.00Strike Price0.00Turnover370.75%IV45.79%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier8DDays to Expiry0.60Extrinsic Value100Contract SizeAmericanOptions Type-0.1018Delta0.0185Gamma28.90Leverage Ratio-0.1046Theta-0.0005Rho-2.94Eff Leverage0.0046Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet